Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)]

Description:

Recombinant monoclonal antibody to Integrin alpha-4/beta-7. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the synthetic antibody Vedolizumab (LDP-02).

Clone Name:
Vedolizumab (LDP-02)
Published Application(s):
therapeutic, FC
Published Species Reactivity:
Human
5
Products based on this clone:
  • {{heading}}
Please Select
  • Ab04181-10.3 Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)]
  • Human
  • Human IgG1
  • Fc Silent™
  • Purified
  • Ships in 5-6 weeks
  • Ab04181-10.0 Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)]
  • Human
  • Human IgG1
  • Purified
  • Ships in 5-6 weeks
  • Ab04181-3.0 Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)]
  • Human
  • Mouse IgG2b
  • Purified
  • Ships in 5-6 weeks
  • Ab04181-3.3 Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)]
  • Human
  • Mouse IgG2b
  • Fc Silent™
  • Purified
  • Ships in 5-6 weeks
  • Ab04181-23.0 Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)]
  • Human
  • Rabbit IgG
  • Purified
  • Ships in 5-6 weeks
Loading...